7-143443755-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_177437.1(TAS2R60):c.303C>A(p.Asp101Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000173 in 1,613,892 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_177437.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAS2R60 | NM_177437.1 | c.303C>A | p.Asp101Glu | missense_variant | 1/1 | ENST00000332690.1 | NP_803186.1 | |
EPHA1-AS1 | NR_033897.1 | n.206+28556C>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAS2R60 | ENST00000332690.1 | c.303C>A | p.Asp101Glu | missense_variant | 1/1 | 6 | NM_177437.1 | ENSP00000327724.1 | ||
EPHA1-AS1 | ENST00000429289.5 | n.206+28556C>A | intron_variant | 1 | ||||||
EPHA1-AS1 | ENST00000690912.1 | n.227+28556C>A | intron_variant | |||||||
EPHA1-AS1 | ENST00000703017.1 | n.205+28556C>A | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152134Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461758Hom.: 0 Cov.: 31 AF XY: 0.0000193 AC XY: 14AN XY: 727192
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152134Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 05, 2024 | The c.303C>A (p.D101E) alteration is located in exon 1 (coding exon 1) of the TAS2R60 gene. This alteration results from a C to A substitution at nucleotide position 303, causing the aspartic acid (D) at amino acid position 101 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at